l 158809 has been researched along with Proteinuria in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berden, JH; Kramer, A; Lensen, J; Navis, G; Rops, A; van den Heuvel, L; van den Hoven, M; van der Vlag, J; van Goor, H; van Kuppevelt, T; Wijnhoven, T | 1 |
| Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
| Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C | 1 |
| Bos, H; De Boer, E; De Jong, PE; De Zeeuw, D; Henning, RH; Navis, G; Tiebosch, AT | 1 |
4 other study(ies) available for l 158809 and Proteinuria
| Article | Year |
|---|---|
Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Topics: Agrin; Angiotensin Receptor Antagonists; Animals; Doxorubicin; Enzyme Induction; Gene Expression Regulation; Glomerular Basement Membrane; Glucuronidase; Heparitin Sulfate; Imidazoles; Kidney Tubules; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Reactive Oxygen Species; Renin-Angiotensin System; Tetrazoles; Thiourea | 2006 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta | 1997 |
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Pressure; Body Weight; Disease Models, Animal; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Imidazoles; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles | 2002 |